Suchergebnisse - "Babiker, Hani M"

PubPharm (93)

11

Exceptional response to cyclophosphamide and dexamethasone in a patient with metastatic castrate-resistant prostate cancer and RB1 mutation

enthalten in: Anti-cancer drugs | 2021

von Dohogne, B. | Arif-Tiwari, H. | Bracamonte, E. | +1

12

Evaluation of Potential Drug‐Drug Interaction Risk of Pexidartinib With Substrates of Cytochrome P450 and P‐Glycoprotein

enthalten in: The Journal of Clinical Pharmacology | 2021

von Zahir, H. | Kobayashi, F. | Zamora, C. | +6

13

Clinical complexity of utilizing FGFR inhibitors in cancer therapeutics

enthalten in: Expert opinion on investigational drugs | 2020

von Chandana, S. | Babiker, H. | Mahadevan, D.

14

Quantitative metric for assessment of pancreatic ductal adenocarcinoma treatment response in T1-weighted gadolinium-enhanced magnetic resonance imaging

enthalten in: Annals of pancreatic cancer | 2020

von Liau, J. | Vedantham, S. | Babiker, H. | +2

15

Implementation of a Low-Cost Quality Improvement Intervention Increases Adherence to Cancer Screening Guidelines and Reduces Healthcare Costs at a University Medical Center

enthalten in: Journal of cancer education : the official journal of the American Association for Cancer Education | 2020

von Recio-Boiles, A. | Karass, M. | Galeas, J. | +3

16

Rare Tumor-Normal Matched Whole Exome Sequencing Identifies Novel Genomic Pathogenic Germline and Somatic Aberrations

enthalten in: Cancers | 2020

von Sprissler, R. | Perkins, B. | Johnstone, L. | +5

17

Correction to : Evaluation of the bioequivalence and food effect on the bioavailability of CC-486 (oral azacitidine) tablets in adult patients with cancer

enthalten in: Cancer chemotherapy and pharmacology | 2020

von Babiker, H. | Milhem, M. | Aisner, J. | +10

ErratumFor: Cancer Chemother Pharmacol. 2020 Mar;85(3):621-626. - PMID 32036412

18

Exposure to proton pump inhibitors and risk of pancreatic cancer : a meta-analysis

enthalten in: Expert opinion on drug safety | 2020

von Alkhushaym, N. | Almutairi, A. | Althagafi, A. | +6

19

Correction to: Evaluation of the bioequivalence and food effect on the bioavailability of CC-486 (oral azacitidine) tablets in adult patients with cancer

enthalten in: Cancer chemotherapy and pharmacology | 2020

von Babiker, H. | Milhem, M. | Aisner, J. | +10

20

Correction to: Evaluation of the bioequivalence and food effect on the bioavailability of CC-486 (oral azacitidine) tablets in adult patients with cancer

enthalten in: Cancer chemotherapy and pharmacology | 2020

von Babiker, H. | Milhem, M. | Aisner, J. | +10